教育培训

师资队伍

  • 人才培养
  • 科研成果

承担课程:临床医学,肿瘤学进展,全科医学,肿瘤学概论,人类形体进化美感研究生培养:已毕业硕士3 名,博士1名

专利:申请国家发明专利 2 项,获授权国家发明专利 2 项奖励荣誉:1. 2019年江苏省医学科技奖一等奖2. 2019年江苏省科学技术奖一等奖 3. 2018年生与健康委员会新技术引进二等奖4. 2017年高等学校科学研究优秀成果(科技进步)二等奖5. 2016年江苏省医学新技术引进一等奖6. 2015年江苏省科学技术奖二等奖7. 2015年江苏省医学科技二等奖8. 2015年中华医学科技三等奖

代表性论文

image.png

1. Wang X, Meng F, Li X, Xue L, Chen A, Qiu Y, Zhang Z, Li L, Liu F, Li Y, Sun Z, Chu Y, Xu R, Yu L, Jie Shao J, Tian M, Qian X, Liu Q, Liu B, Li R. Nano-Modified Switch Induced Precise and Moderate Activation of CAR-T Cells for Solid Tumors.  2023 Adv Sci accepted

2. Zhu J, Ke Y, Liu Q, Yang J, Liu F, Xu R, Zhou H, Chen A, Xiao J, Meng F, Yu L, Li R, Wei J, Liu B. Engineered Lactococcus lactis secreting Flt3L and OX40 ligand for in situ vaccination-based cancer immunotherapy.

Nat Commun. 2022 Dec 3;13(1):7466. doi: 10.1038/s41467-022-35130-7. PMID: 36463242

3. Sun Z, Li R, Shen Y, Tan S, Ding N, Xu R, Wang X, Wei J, Liu B, Meng F. In situ antigen modification-based target-redirected universal chimeric antigen receptor T (TRUE CAR-T) cell therapy in solid tumors. J Hematol Oncol. 2022 Mar 18;15(1):29. doi: 10.1186/s13045-022-01246-y. PMID: 35303900

4. Wang X, Gao J, Li C, Xu C, Li X, Meng F, Liu Q, Wang Q, Yu L, Liu B, Li R. In situ gelatinase-responsive and thermosensitive nanocomplex for local therapy of gastric cancer with peritoneal metastasis. Mater Today Bio. 2022 May 31;15:100305. PMID: 35734198 

5. Chu Y, Li R, Qian L, Liu F, Xu R, Meng F, Ke Y, Shao J, Yu L, Liu Q, Liu B. Tumor eradicated by combination of imiquimod and OX40 agonist for in situ vaccination. Cancer Sci. 2021 Nov;112(11):4490-4500. doi: 10.1111/cas.15145. Epub 2021 Sep 27. PMID: 34537997 

6. Wang X, Meng F, Yen Y, Li R, Liu B. Nanotechnology-Based CAR-T Strategies for Improving Efficacy and Safety of Tumor Immunotherapy. Adv. Funct. Mater. 2020, 2004713

7. Wang X, Meng F, Li X, Xue L, Chen A, Qiu Y, Zhang Z, Li L, Liu F, Li Y, Sun Z, Chu Y, Xu R, Yu L, Jie Shao J, Tian M, Qian X, Liu Q, Liu B, Li R. Nano-Modified Switch Induced Precise and Moderate Activation of CAR-T Cells for Solid Tumors.  2023 Adv Sci accepted

代表性教材与专著

《肿瘤个体化与靶向免疫治疗学》

Personalized Management of Gastric Cancer: Translational and Precision Medicine》


Copyright © 2004-2018 www.njglyy.com. All rights reserved. 南京鼓楼医院版权所有

技术支持:恒网 苏ICP备11032818号-1 公安备案号:32010602010034